Vera Therapeutics (VERA) Insider Trading & Ownership → “Crash Insurance” For Your Retirement (From Unstoppable Prosperity) (Ad) Free VERA Stock Alerts $44.94 -0.06 (-0.13%) (As of 05/8/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Vera Therapeutics (NASDAQ:VERA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage21.70%Number OfInsiders Buying(Last 12 Months)3Amount OfInsider Buying(Last 12 Months)$11.88 MNumber OfInsiders Selling(Last 12 Months)6Amount OfInsider Selling(Last 12 Months)$40.54 M Get VERA Insider Trade Alerts Want to know when executives and insiders are buying or selling Vera Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address VERA Insider Buying and Selling by Quarter Ad Behind the MarketsThe Weight Loss Pill That Could Disrupt a $32 Billion IndustryA revolutionary new weight loss pill is about to send shockwaves through the plus-size clothing market. Analysts are calling it the "King Kong" of diet drugs after amazing clinical trial results.Don't miss out on the "next Ozempic" >>> Vera Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails4/10/2024Joseph R YoungSVPSell5,714$40.00$228,560.00 4/3/2024Sean GrantCFOSell99,828$39.61$3,954,187.08 3/25/2024Maha KatabiDirectorSell340,000$40.50$13,770,000.00 3/21/2024Maha KatabiDirectorSell81,009$44.20$3,580,597.80 1/30/2024Maha KatabiDirectorBuy161,290$31.00$4,999,990.00 1/10/2024Commodore Capital LpMajor ShareholderSell1,050,000$18.00$18,900,000.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 8/21/2023Celia LinInsiderSell1,490$16.65$24,808.50 8/21/2023Marshall FordyceCEOSell5,210$16.66$86,798.60 6/23/2023Sean GrantCFOBuy5,000$16.60$83,000.00 6/20/2023Commodore Capital LpMajor ShareholderBuy448,217$15.17$6,799,451.89 (Data available from 1/1/2013 forward) VERA Insider Trading Activity - Frequently Asked Questions Who is on Vera Therapeutics's Insider Roster? The list of insiders at Vera Therapeutics includes Beth C Seidenberg, Carlyle Group Inc., Celia Lin, Commodore Capital Lp, Joanne Curley, Joseph R Young, Llp Abingworth, Maha Katabi, Marshall Fordyce, Patrick G Enright, Sean Grant, and Sofinnova Venture Partners X,. Learn more on insiders at VERA. What percentage of Vera Therapeutics stock is owned by insiders? 21.70% of Vera Therapeutics stock is owned by insiders. Learn more on VERA's insider holdings. Which Vera Therapeutics insiders have been buying company stock? The following insiders have purchased VERA shares in the last 24 months: Beth C Seidenberg ($2,000,102.98), Commodore Capital Lp ($6,799,451.89), Maha Katabi ($4,999,990.00), Patrick G Enright ($11,999,995.00), Sean Grant ($151,000.00), and Sofinnova Venture Partners X, ($1,999,998.00). How much insider buying is happening at Vera Therapeutics? Insiders have purchased a total of 2,898,308 VERA shares in the last 24 months for a total of $27,950,537.87 bought. Which Vera Therapeutics insiders have been selling company stock? The following insiders have sold VERA shares in the last 24 months: Carlyle Group Inc. ($200,981.25), Celia Lin ($24,808.50), Commodore Capital Lp ($18,900,000.00), Joanne Curley ($1,365,447.38), Joseph R Young ($228,560.00), Maha Katabi ($17,350,597.80), Marshall Fordyce ($1,529,810.61), and Sean Grant ($3,954,187.08). How much insider selling is happening at Vera Therapeutics? Insiders have sold a total of 1,741,087 Vera Therapeutics shares in the last 24 months for a total of $43,554,392.62 sold. More Insider Trading Tools from MarketBeat Related Companies: Geron Insider Buying Arvinas Insider Buying Dyne Therapeutics Insider Buying TG Therapeutics Insider Buying Deciphera Pharmaceuticals Insider Buying Maravai LifeSciences Insider Buying Keros Therapeutics Insider Buying Amphastar Pharmaceuticals Insider Buying Rocket Pharmaceuticals Insider Buying NewAmsterdam Pharma Insider Buying Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year This page (NASDAQ:VERA) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityWatch this FREE trading tutorial while it’s still availableInvestorPlaceShocking: One AI startup's revenue could surge 4,735%Manward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vera Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.